Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Al18F: A New Standard for Radiofluorination

David M. Goldenberg, Robert M. Sharkey, William J. McBride and Otto C. Boerman
Journal of Nuclear Medicine July 2013, 54 (7) 1170; DOI: https://doi.org/10.2967/jnumed.113.125245
David M. Goldenberg
*Center for Molecular Medicine and Immunology, 520 Belleville Ave., Belleville, NJ 07109. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dmg.gscancer@att.net
Robert M. Sharkey
*Center for Molecular Medicine and Immunology, 520 Belleville Ave., Belleville, NJ 07109. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dmg.gscancer@att.net
William J. McBride
*Center for Molecular Medicine and Immunology, 520 Belleville Ave., Belleville, NJ 07109. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dmg.gscancer@att.net
Otto C. Boerman
*Center for Molecular Medicine and Immunology, 520 Belleville Ave., Belleville, NJ 07109. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dmg.gscancer@att.net
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: 18F is the most common radionuclide used in PET imaging, but its application via a rapid, simple, easily accessible labeling procedure has been challenging. We congratulate Wan et al. for their recent article appearing online on April 3 and in the printed journal in May (1) on the clinical validation of the Al18F labeling method involving an RGD peptide labeled essentially by applying the facile, 1-step method first reported in 2009 (2). Subsequent improvements also have been described (3–5), including the first report of a kit formulation of a peptide for additional simplification and enhancement of the Al18F labeling procedure (3). It is gratifying to read the utility of this procedure applied to a specific RGD peptide, alfatide, for successful imaging of lung cancer, confirming the Al18F labeling of RGD described recently by the National Institutes of Health group, as well as Liu et al. in 2011 (6), Shetty et al. in 2012 (7), and Dijkgraaf et al. in 2013 (8). This technique now can be extended to other peptides for simple radiofluorination, not requiring an on-site cyclotron by using sodium fluoride commonly available for bone imaging (3). By translation of the Al18F procedure into clinical practice, the extensive research and development conducted—which has been reviewed elsewhere (9)—has now been validated for the first time in humans.

DISCLOSURE

The Al18F project was supported in part by the National Center for Research Resources and the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health through grant 5-R44-RR-028018-03. Drs. Goldenberg, Sharkey, and McBride are employed by and have stock in Immunomedics, Inc. Drs. Goldenberg and McBride are inventors of 10 U.S. patents issued on Al18F technology. No other potential conflict of interest relevant to this letter was reported.

Footnotes

  • Published online May 17, 2013.

  • © 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

REFERENCES

  1. 1.↵
    1. Wan W,
    2. Guo N,
    3. Pan D,
    4. et al
    . First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J Nucl Med. 2013;54:691–698.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. McBride WJ,
    2. Sharkey RM,
    3. Karacay H,
    4. et al
    . A novel method of 18F radiolabeling for PET. J Nucl Med. 2009;50:991–998.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. McBride WJ,
    2. D’Souza CA,
    3. Karacay H,
    4. Sharkey RM,
    5. Goldenberg DM
    . New lyophilized kit for rapid radiofluorination of peptides. Bioconjug Chem. 2012;23:538–547.
    OpenUrlCrossRefPubMed
  4. 4.
    1. McBride WJ,
    2. D’Souza CA,
    3. Sharkey RM,
    4. et al
    . Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem. 2010;21:1331–1340.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. D’Souza CA,
    2. McBride WJ,
    3. Sharkey RM,
    4. Todaro LJ,
    5. Goldenberg DM
    . High-yielding aqueous 18F-labeling of peptides via Al18F chelation. Bioconjug Chem. 2011;22:1793–1803.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Liu S,
    2. Liu H,
    3. Jiang H,
    4. Xu Y,
    5. Zhang H,
    6. Cheng Z
    . One-step radiosynthesis of 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging. 2011;38:1732–1741.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Shetty D,
    2. Jeong DS,
    3. Kim YJ,
    4. et al
    . Development of a bifunctional chelating agent containing isothiocyanate residue for one step F-18 labeling of peptides and applications for RGD labeling. Bioorg Med Chem. 2012;20:5941–5947.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Dijkgraaf I,
    2. Terry SYA,
    3. McBride WJ,
    4. et al
    . Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide. Contrast Media Mol Imaging. 2013;8:238–245.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. McBride WJ,
    2. Sharkey RM,
    3. Goldenberg DM
    . Radiofluorination using aluminum-fluoride (Al18F). EJNMMI Res. May 8, 2013 [Epub ahead of print].
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (7)
Journal of Nuclear Medicine
Vol. 54, Issue 7
July 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Al18F: A New Standard for Radiofluorination
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Al18F: A New Standard for Radiofluorination
David M. Goldenberg, Robert M. Sharkey, William J. McBride, Otto C. Boerman
Journal of Nuclear Medicine Jul 2013, 54 (7) 1170; DOI: 10.2967/jnumed.113.125245

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Al18F: A New Standard for Radiofluorination
David M. Goldenberg, Robert M. Sharkey, William J. McBride, Otto C. Boerman
Journal of Nuclear Medicine Jul 2013, 54 (7) 1170; DOI: 10.2967/jnumed.113.125245
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
  • The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire